Basic Information
Sigyn Therapeutics' belief is that device-based therapies can be designed to address significant unmet needs in the global health field. The Sigyn Therapy™ we have developed reflects this belief—a versatile blood purification technology capable of extracting pathogen sources responsible for life-threatening inflammation while broadly eliminating inflammatory mediators from the bloodstream. Based on these capabilities, Sigyn Therapy™ is a candidate for addressing pathogen-associated conditions that trigger sepsis and other life-threatening inflammatory diseases.
Sigyn Therapeutics, Inc
SanDiego,California,United States of America
unclear
January 01, 1971
--

